Talent Acquisition Jobs in Menlo Park, CA

About Us Catalyst Labs is a specialized talent agency with a specialized vertical in Recruitment People Operations and Talent Acquisition. We embed ourselves directly into our clients hiring infrastructure functioning as an extension of their internal talent teams and leadership not as an external v...

Location: On-site 4 days per week at our Menlo Park CA Princeton NJ or Miami FL office.About Summit: Ivonescimab also known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effect...

Location:On-site 4 days per week at our Menlo Park CA Princeton NJ or Miami FL locationsAbout SummitIvonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects asso...

Location: Palo Alto CA / Miami FL / Princeton NJ onsiteAbout Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a...

Our Client Has raised seventeen million dollars in funding and is building an innovative open source visual AI platform that allows anyone to create generative workflows through an intuitive code free interface. Their platform uses a visual node based system that enables artists creators and technic...

**THIS IS A CONTRACT POSITION**LOCATION: Ideal candidate will be based on the west coast (PST)Overview of Role:Talent Acquisition (TA) Coordinator is responsible for the timely and efficient support of the day-to-day Talent Acquisition operations from recruitment through the addition this position...

About Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooperati...

About Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooperati...

Location: Menlo Park CA Princeton NJ or Miami FL onsiteAbout Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a...

About Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooperati...

About Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooperati...

About Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooperati...

Location: On-Site 4 days per week at our Menlo Park CA Miami FL or Princeton NJ officeAbout Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects assoc...

Location: Princeton NJ or Palo Alto CA onsiteAbout Summit: Ivonescimab also known as SMT112 is a novel potential first-in-class investigational bispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a s...

About Summit: Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooperat...

Location: On-Site 4 days per week at our Menlo Park CA officeAbout Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF...

About Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooperati...

About Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooperati...

OverviewOpportunity: Director of Human ResourcesHotel Nia is a contemporary luxury property defined by excellence in service and a culture of genuine connection. Were seeking a Director of Human Resources who brings both strategic insight and a people-first mindset. This leader will oversee all face...

Location: On-Site 4 days per week at our Menlo Park CA Miami FL or Princeton NJ officeAbout Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects assoc...